Milad Alucozai is a venture capital investor at BoxOne Ventures who started as a bench scientist in translational neuroscience and multiphysics labs before founding multiple healthcare and bio startups, including Mekonos and Corstem, giving him deep technical and operator experience that he now brings to early-stage founders. He co-founded Revalia Bio, which uses non-transplantable human organs donated for research to create human-relevant infrastructure for drug discovery, and serves as a Venture Partner at Entrepreneur First while mentoring at elite institutions like the Wyss Institute at Harvard, where he co-launched the Code to Cure series focused on AI and biology convergence. Milad Alucozai is a venture capital investor at BoxOne Ventures who started as a bench scientist in translational neuroscience and multiphysics labs before founding multiple healthcare and bio startups, including Mekonos and Corstem, giving him deep technical and operator experience that he now brings to early-stage founders. He co-founded Revalia Bio, which uses non-transplantable human organs donated for research to create human-relevant infrastructure for drug discovery, and serves as a Venture Partner at Entrepreneur First while mentoring at elite institutions like the Wyss Institute at Harvard, where he co-launched the Code to Cure series focused on AI and biology convergence.